Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Current Opinion in Hematology|September 3, 2021
The role of biomarkers in risk stratification, treatment and outcome in acute GVHDSaara Kaviany, Carrie L KitkoTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 10, 2015
Extracorporeal photopheresis in prevention and treatment of acute GVHDCarrie L Kitko, John E LevinePediatric Transplantation|October 24, 2009
Successful unrelated donor cord blood transplantation for Glanzmann's thrombastheniaCarrie L Kitko, John E Levine, Dana C Matthews, et al.Pediatric Transplantation|June 3, 2020
Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomesAlex Tinianow, James C Gay, David W Bearl, et al.Annals of Plastic Surgery|January 23, 2026
Bidirectional Interactions: Microbiome and Immune System Function in Cutaneous Graft-Versus-Host DiseaseBenjamin L Savitz, Kylie Duckworth, Hanna L Slutsky, et al.Transplantation and Cellular Therapy|February 18, 2026
Longitudinal Study of Late Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: A Long-Term Follow-up Study from the Chronic Graft-Versus-Host Disease ConsortiumJoseph Pidala, Lynn Onstad, Paul Carpenter, et al.Annals of Plastic Surgery|June 11, 2026
Skin Lesion Reconstruction in Graft Versus Host Disease Using Autograft From the Bone Marrow Donor Panniculectomy TissueDaniella King, Maria Kalogeromitros, Barite Gutama, et al.Frontiers in Pediatrics|April 11, 2022
Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?Jacob Rozmus, Sima T Bhatt, Nataliya Prokopenko Buxbaum, et al.Blood Advances|June 17, 2024
Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantationJoseph A Pidala, Lynn Onstad, Emily Baumrin, et al.Blood Reviews|June 25, 2022
SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapiesBin Ni, Ahmad Yanis, Kevin Dee, et al.Pageof 10